Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Plant mitochondrial genome engineering: technology development and application to study fundamental aspects of mitochondrial gene expression

Project description

Engineering plant mitochondrial genomes

Plants contain mitochondrial genomes that are much more complex and larger than those of animal cells. Plant mitochondrial DNA undergoes frequent recombination and many of its genes have been transferred to the nuclear genome over evolution. The key objective of the ERC-funded PlaMitEng project is to make the mitochondrial genome of seed plants amenable to genetic engineering. Researchers will study plant mitochondrial gene expression and develop a technology for direct genetic transformation of the plant mitochondrial genome, which has been challenging due to the lack of a mitochondrion-specific selection system. By establishing a robust mitochondrial transformation method, the project will unlock the potential of mitochondrial biotechnology and synthetic biology.

Objective

PlaMitEng has the highly ambitious overall objective to make the mitochondrial genome of seed plants amenable to genetic engineering. The project consists of two complementary work packages (WPs). In WP1, TALEN-GDM, a technology for plant mitochondrial genome editing recently developed by us will be used to systematically study plant mitochondrial gene expression in vivo. The focus will be on translation initiation and translational regulation in mitochondria, the mechanisms of which are currently completely unknown. In WP2, PlaMitEng will develop a technology for direct genetic transformation of the plant mitochondrial genome. The mitochondrial genome is the only genome of the plant cell that, due to the lack of a mitochondrion-specific selection system, is not amenable to transformation and has remained recalcitrant to the insertion and expression of transgenes. Taking advantage of (i) our recent construction of a mitochondrion-specific selectable marker gene, (ii) the generation of a dedicated recipient line for mitochondrial transformation, and (iii) the design of a new transformation strategy (referred to as multivectorial transformation) that will enable the large-scale testing of expression elements for their suitability to drive the expression of mitochondrial transgenes in vivo, PlaMitEng will pursue the development of a robust technology for transformation of the plant mitochondrial genome. The possibility to express transgenes from plant mitochondrial genomes will open up entirely new opportunities in both basic and applied research, and pave the way to harnessing the enormous potential of mitochondrial biotechnology and synthetic biology.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2023-ADG

See all projects funded under this call

Host institution

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
Net EU contribution
€ 2 500 000,00
Address
HOFGARTENSTRASSE 8
80539 MUNCHEN
Germany
Region
Berlin Berlin Berlin
Activity type
Research Organisations
Links
Total cost
€ 2 500 000,00

Beneficiaries (1)